Humoral immune response and protection from viral infection in mice vaccinated with inactivated MHV-68:: Effects of type I interferon

被引:10
作者
Aricò, E
Robertson, K
Allen, D
Ferrantini, M
Belardelli, F
Nash, AA
机构
[1] Ist Super Sanita, Virol Lab, I-00161 Rome, Italy
[2] Univ Edinburgh, Dept Vet Pathol, Edinburgh EH9 1QH, Midlothian, Scotland
关键词
D O I
10.1089/10799900260442502
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Infection of mice by murine gammaherpesvirus 68 (MHV-68) represents a suitable animal model in which to investigate the immune response against gammaherpesviruses and to test the efficacy of vaccination strategies. In this study, we evaluated the efficacy of heat-inactivated MHV-68 as a vaccine as well as the adjuvant activity of type I interferon (IFN-I) administered together with the vaccine. Mice vaccinated with inactivated MHV-68 and subsequently infected with the virus exhibited a significant augmentation of the virus-specific humoral immune response and a considerable inhibition of MHV-68 acute replication in the lungs compared with unvaccinated control mice. The coadministration of IFN-I with inactivated MHV-68 significantly enhanced the humoral immune response elicited by the vaccine by stimulating the production of virus-specific IgG2 antibodies but did not significantly enhance protection from viral challenge. We conclude that IFN-I, recently shown to exhibit a powerful adjuvant activity to a poorly immunogenic subunit vaccine in mice, can also enhance the humoral immune response when used as adjuvant of an inactivated viral vaccine, even though this effect is less marked as a result of the strong immune response elicited by the inactivated virus alone, which may also involve the contribution of endogenous IFN.
引用
收藏
页码:1081 / 1088
页数:8
相关论文
共 35 条
[1]   The neglected role of type I interferon in the T-cell response: Implications for its clinical use [J].
Belardelli, F ;
Gresser, I .
IMMUNOLOGY TODAY, 1996, 17 (08) :369-372
[2]   ROLE OF INTERFERONS AND OTHER CYTOKINES IN THE REGULATION OF THE IMMUNE-RESPONSE [J].
BELARDELLI, F .
APMIS, 1995, 103 (03) :161-179
[3]   Strategies for designing and optimizing new generation vaccines [J].
Berzofsky, JA ;
Ahlers, JD ;
Belyakov, IM .
NATURE REVIEWS IMMUNOLOGY, 2001, 1 (03) :209-219
[4]  
BLASKOVIC D, 1980, ACTA VIROL, V24, P468
[5]   The function of type I interferons in antimicrobial immunity [J].
Bogdan, C .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (04) :419-424
[6]  
BRAUN W, 1972, P SOC EXP BIOL MED, V141, P769
[7]  
BRODEUR BR, 1974, J IMMUNOL, V113, P1319
[8]  
BRODEUR BR, 1975, J IMMUNOL, V114, P1323
[9]   Progressive loss of CD8(+) T cell-mediated control of a gamma-herpesvirus in the absence of CD4(+) T cells [J].
Cardin, RD ;
Brooks, JW ;
Sarawar, SR ;
Doherty, PC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :863-871
[10]   SUPPRESSION OF MOUSE ANTIBODY-PRODUCING SPLEEN-CELLS BY VARIOUS INTERFERON PREPARATIONS [J].
CHESTER, TJ ;
PAUCKER, K ;
MERIGAN, TC .
NATURE, 1973, 246 (5428) :92-94